BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

423 related articles for article (PubMed ID: 20101004)

  • 41. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance.
    Singh I; Sagare AP; Coma M; Perlmutter D; Gelein R; Bell RD; Deane RJ; Zhong E; Parisi M; Ciszewski J; Kasper RT; Deane R
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14771-6. PubMed ID: 23959870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intracranial IL-17A overexpression decreases cerebral amyloid angiopathy by upregulation of ABCA1 in an animal model of Alzheimer's disease.
    Yang J; Kou J; Lalonde R; Fukuchi KI
    Brain Behav Immun; 2017 Oct; 65():262-273. PubMed ID: 28526436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of the ATP-binding cassette transporter P-glycoprotein in the transport of β-amyloid across the blood-brain barrier.
    Vogelgesang S; Jedlitschky G; Brenn A; Walker LC
    Curr Pharm Des; 2011; 17(26):2778-86. PubMed ID: 21827406
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired Amyloid Beta Clearance and Brain Microvascular Dysfunction are Present in the Tg-SwDI Mouse Model of Alzheimer's Disease.
    Rosas-Hernandez H; Cuevas E; Raymick JB; Robinson BL; Sarkar S
    Neuroscience; 2020 Aug; 440():48-55. PubMed ID: 32450297
    [TBL] [Abstract][Full Text] [Related]  

  • 45. α(2A) adrenergic receptor promotes amyloidogenesis through disrupting APP-SorLA interaction.
    Chen Y; Peng Y; Che P; Gannon M; Liu Y; Li L; Bu G; van Groen T; Jiao K; Wang Q
    Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17296-301. PubMed ID: 25404298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier.
    Osgood D; Miller MC; Messier AA; Gonzalez L; Silverberg GD
    Neurobiol Aging; 2017 Sep; 57():178-185. PubMed ID: 28654861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Omega-3 polyunsaturated fatty acids promote brain-to-blood clearance of β-Amyloid in a mouse model with Alzheimer's disease.
    Yan L; Xie Y; Satyanarayanan SK; Zeng H; Liu Q; Huang M; Ma Y; Wan JB; Yao X; Su KP; Su H
    Brain Behav Immun; 2020 Mar; 85():35-45. PubMed ID: 31132459
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Secretion and accumulation of Abeta by brain vascular smooth muscle cells from AbetaPP-Swedish transgenic mice.
    Frackowiak J; Miller DL; Potempska A; Sukontasup T; Mazur-Kolecka B
    J Neuropathol Exp Neurol; 2003 Jun; 62(6):685-96. PubMed ID: 12834113
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Knockout of apolipoprotein A-I decreases parenchymal and vascular β-amyloid pathology in the Tg2576 mouse model of Alzheimer's disease.
    Contu L; Carare RO; Hawkes CA
    Neuropathol Appl Neurobiol; 2019 Dec; 45(7):698-714. PubMed ID: 31002190
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Up-regulation of P-glycoprotein reduces intracellular accumulation of beta amyloid: investigation of P-glycoprotein as a novel therapeutic target for Alzheimer's disease.
    Abuznait AH; Cain C; Ingram D; Burk D; Kaddoumi A
    J Pharm Pharmacol; 2011 Aug; 63(8):1111-8. PubMed ID: 21718295
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer's disease.
    Dutescu RM; Li QX; Crowston J; Masters CL; Baird PN; Culvenor JG
    Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1213-21. PubMed ID: 19271231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oleocanthal-rich extra-virgin olive oil enhances donepezil effect by reducing amyloid-β load and related toxicity in a mouse model of Alzheimer's disease.
    Batarseh YS; Kaddoumi A
    J Nutr Biochem; 2018 May; 55():113-123. PubMed ID: 29413486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
    Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
    Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP/PS1 transgenic AD mice.
    Zhang S; Zhi Y; Li F; Huang S; Gao H; Han Z; Ge X; Li D; Chen F; Kong X; Lei P
    J Neurol Sci; 2018 Apr; 387():6-15. PubMed ID: 29571873
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oleocanthal enhances amyloid-β clearance from the brains of TgSwDI mice and in vitro across a human blood-brain barrier model.
    Qosa H; Batarseh YS; Mohyeldin MM; El Sayed KA; Keller JN; Kaddoumi A
    ACS Chem Neurosci; 2015 Nov; 6(11):1849-59. PubMed ID: 26348065
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease.
    Xiong H; Callaghan D; Wodzinska J; Xu J; Premyslova M; Liu QY; Connelly J; Zhang W
    Neurosci Bull; 2011 Aug; 27(4):221-32. PubMed ID: 21788993
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.
    Yan Q; Zhang J; Liu H; Babu-Khan S; Vassar R; Biere AL; Citron M; Landreth G
    J Neurosci; 2003 Aug; 23(20):7504-9. PubMed ID: 12930788
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of ABC transporters in the pathogenesis of Alzheimer's disease.
    Abuznait AH; Kaddoumi A
    ACS Chem Neurosci; 2012 Nov; 3(11):820-31. PubMed ID: 23181169
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterization of Hit Compounds Identified from High-throughput Screening for their Effect on Blood-brain Barrier Integrity and Amyloid-β Clearance: In Vitro and In Vivo Studies.
    Elfakhri KH; Duong QV; Langley C; Depaula A; Mousa YM; Lebeouf T; Cain C; Kaddoumi A
    Neuroscience; 2018 May; 379():269-280. PubMed ID: 29596966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.